ESTRELLA IMMUNOPHARMA, INC. Basic Shares Outstanding (Weighted Average)
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Basic Shares Outstanding (Weighted Average) of 43.00 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- ESTRELLA IMMUNOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 43.00M shares, a 18.89% increase year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 42.12M shares, a 16.39% increase year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 37.82M shares, a 2.72% increase year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 37.10M shares, a 2.45% increase year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 36.82M shares.
- ESTRELLA IMMUNOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 27.10M shares, a 8764.81% increase from fiscal 2023.
- ESTRELLA IMMUNOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 305.75K shares.
- ESTRELLA IMMUNOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 1.18M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 43.00M shares 10-Q · filed 2026-08-13 | 42.56M shares 10-Q · filed 2026-08-13 | 40.98M shares derived: average of 3 quarters · filed 2026-08-13 | 40.01M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | 42.12M shares 10-Q · filed 2026-05-18 | 39.97M shares derived: average of 2 quarters · filed 2026-05-18 | 39.01M shares derived: average of 3 quarters · filed 2026-05-18 | 38.30M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | 37.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 37.46M shares derived: average of 2 quarters · filed 2026-03-18 | 37.03M shares derived: average of 3 quarters · filed 2026-08-13 | 36.82M shares 10-K · filed 2026-03-18 | |
| 2025-09-30 | 37.10M shares 10-Q · filed 2025-11-12 | 36.63M shares derived: average of 2 quarters · filed 2026-08-13 | 36.49M shares 10-Q · filed 2025-11-12 | 36.57M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | 36.17M shares 10-Q · filed 2026-08-13 | 36.18M shares 10-Q · filed 2026-08-13 | 36.39M shares derived: average of 3 quarters · filed 2026-08-13 | 36.35M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | 36.19M shares 10-Q · filed 2026-05-18 | 36.51M shares derived: average of 2 quarters · filed 2026-05-18 | 36.41M shares derived: average of 3 quarters · filed 2026-05-18 | 36.40M shares derived: average of 4 quarters · filed 2026-05-18 | |
| 2024-12-31 | 36.82M shares derived: 10-K 6 month − 10-Q 3 month · filed 2026-03-18 | 36.52M shares 10-K · filed 2026-03-18 | 36.47M shares derived: average of 3 quarters · filed 2026-03-18 | 36.23M shares derived: average of 4 quarters · filed 2026-03-18 | |
| 2024-09-30 | 36.21M shares 10-Q · filed 2025-11-12 | 36.29M shares derived: average of 2 quarters · filed 2025-11-12 | 36.19M shares 10-Q · filed 2025-11-12 | 35.83M shares derived: average of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | 36.38M shares 10-Q · filed 2025-08-12 | 36.18M shares 10-Q · filed 2025-08-12 | 35.70M shares derived: average of 3 quarters · filed 2025-08-12 | 27.10M shares 10-KT · filed 2025-03-25 | |
| 2024-03-31 | 35.52M shares 10-Q · filed 2025-05-14 | 35.36M shares derived: average of 2 quarters · filed 2025-05-14 | 23.96M shares 10-Q · filed 2024-05-15 | 18.09M shares derived: average of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | 35.20M shares 10-Q · filed 2024-02-14 | 18.13M shares 10-Q · filed 2024-02-14 | 12.28M shares derived: average of 3 quarters · filed 2024-11-14 | 9.30M shares derived: average of 4 quarters · filed 2024-11-14 | |
| 2023-09-30 | 1.05M shares 10-Q · filed 2024-11-14 | 823.11K shares derived: average of 2 quarters · filed 2024-11-14 | 661.16K shares derived: average of 3 quarters · filed 2024-11-14 | 538.06K shares derived: average of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | 593.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | 465.42K shares derived: average of 2 quarters · filed 2024-09-27 | 366.53K shares derived: average of 3 quarters · filed 2024-09-27 | 305.75K shares 10-K · filed 2024-09-27 | |
| 2023-03-31 | 337.27K shares 10-Q · filed 2024-05-15 | 253.02K shares derived: average of 2 quarters · filed 2024-05-15 | 209.81K shares 10-Q · filed 2024-05-15 | 502.44K shares derived: average of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | 168.76K shares 10-Q · filed 2024-02-14 | 126.40K shares 10-Q · filed 2024-02-14 | 557.50K shares derived: average of 3 quarters · filed 2024-02-14 | 773.05K shares derived: average of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | 84.04K shares 10-Q · filed 2023-11-20 | 1.42M shares 10-Q · filed 2022-11-14 | 751.87K shares derived: average of 2 quarters · filed 2023-11-20 | 1.42M shares 10-Q · filed 2022-11-14 | 1.09M shares derived: average of 4 quarters · filed 2023-11-20 |
| 2022-06-30 | 1.42M shares 10-Q · filed 2022-08-08 | 1.42M shares 10-Q · filed 2022-08-08 | 1.42M shares derived: average of 3 quarters · filed 2022-08-08 | 1.39M shares derived: average of 4 quarters · filed 2022-11-14 | |
| 2022-03-31 | 1.42M shares 10-Q · filed 2022-05-16 | 1.42M shares derived: average of 2 quarters · filed 2022-05-16 | 1.38M shares derived: average of 3 quarters · filed 2022-11-14 | 1.28M shares derived: average of 4 quarters · filed 2022-11-14 | |
| 2021-12-31 | 1.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 1.35M shares derived: average of 2 quarters · filed 2022-11-14 | 1.24M shares derived: average of 3 quarters · filed 2022-11-14 | 1.18M shares 10-K · filed 2022-03-29 | |
| 2021-09-30 | 1.28M shares 10-Q · filed 2022-11-14 | 1.14M shares derived: average of 2 quarters · filed 2022-11-14 | 1.10M shares 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | 1.00M shares 10-Q · filed 2022-08-08 | 1.00M shares 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | 1.00M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |